authors
- Ismaila, Afisi
- Haeussler, Katrin
- Malmenäs, Mia
- Sharma, Raj
- Compton, Chris
- Vogelmeier, Claus F
- Han, MeiLan K
- Halpin, David MG
A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2023
has subject area
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- Administration, Inhalation (MeSH)
- Androstadienes (MeSH)
- Benzyl Alcohols (MeSH)
- Bronchodilator Agents (MeSH)
- Chlorobenzenes (MeSH)
- Drug Combinations (MeSH)
- Fluticasone (MeSH)
- General Clinical Medicine (Science Metrix)
- Humans (MeSH)
- Network Meta-Analysis (MeSH)
- Pulmonary Disease, Chronic Obstructive (MeSH)
- Quinuclidines (MeSH)
published in
- Advances in Therapy Journal